|
News European Medicines Agency recommends suspension of Avandia, Avandamet and Avaglim
Anti-diabetes medication to be taken off the market |
|
News CHMP meets to discuss Avandia and Pandemrix
The Committee for Medicinal Products for Human Use (CHMP) met on Wednesday 8 September to discuss the ongoing benefit-risk review of the rosiglitazone-containing medicines Avandia, Avandamet and Avaglim. |
|
News CHMP meeting on 8 September 2010 to discuss Avandia and Pandemrix
The Committee for Medicinal Products for Human Use (CHMP) is meeting on Wednesday 8 September to discuss the ongoing benefit-risk review of the rosiglitazone-containing medicines Avandia, Avandamet and Avaglim. |
|
News European Medicines Agency update on ongoing benefit-risk review of Avandia, Avandamet and Avaglim
Doctors reminded to follow current restrictions for rosiglitazone-containing anti-diabetes medicines until further notice |
|
Leaflet Drug Avaglim
Avaglim is a medicine that contains two active substances, rosiglitazone and glimepiride. |